Biotia
Clinical metagenomic diagnostics for challenging infectious diseases
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
Biotia develops clinical metagenomic infectious disease diagnostics and pathogen genomics software. Products include the BIOTIA-ID Urine Test for urogenital pathogens and antimicrobial resistance markers, a joint-fluid test, BIOTIA-DX for hospital isolate identification and outbreak detection, and GeoSeeq for genomic surveillance used by organizations across many countries. The company has publicly reported a $9 million venture financing round and serves patients, health systems, and research partners.
- Website
- biotia.io
- Stage
- series-a
- Location
- United States
- Added via
- web
- Ownership
- unclaimed
Where to go
Products
- BIOTIA-ID Urine Test — Metagenomic urine test for urogenital pathogens and AMR markers
- GeoSeeq — Cloud platform for genomic surveillance and microbiome research